Eli Lilly Ends Coronavirus Antibody Treatment Trial, Other Studies Go On
The trial studied the efficacy of bamlanivimab and remdesivir on hospitalized COVID-19 patients - the same therapies given to President Trump. But researchers say people showed no marked improvement.